Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Tadalafil is not FDA-approved for women, though it is sometimes used off-label, and it has no known major interaction with hormonal birth control or with most SSRIs and SNRIs. Still, there are several important factors to weigh, including nitrates and blood pressure medications, a history of low blood pressure or fainting, dizziness, headaches, and how your antidepressant may itself be affecting libido or arousal, all detailed below. Because low desire, arousal difficulty, or pain can stem from hormones, medication side effects, thyroid issues, or mood conditions rather than blood flow, identifying the real cause first usually matters more than adding another pill. A free, instant, online symptom check can help you sort through your symptoms and current medications in minutes, so you walk into your next appointment knowing which questions to ask and which next steps make sense for you.
Last reviewed for medical accuracy: 09/13/2026
Tadalafil is best known as a treatment for erectile dysfunction (ED), but it also has FDA approval for pulmonary arterial hypertension (PAH) under the brand name Adcirca. Off-label, some clinicians may consider it for female sexual arousal disorder or other circulatory issues. If you’re a woman on hormonal birth control and/or antidepressants, you may wonder whether it’s safe to add tadalafil to your regimen. Here’s a clear, evidence-based look at what you need to know.
• Mechanism of Action
• Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor.
• It boosts blood flow by relaxing smooth muscle in blood vessel walls.
• Common Uses
• Erectile dysfunction in men (Cialis).
• Pulmonary arterial hypertension in adults (Adcirca).
• Off-label in some cases for female sexual arousal issues.
• Key Pharmacology
• Oral tablets; onset 30–60 minutes; effect lasts up to 36 hours.
• Metabolized primarily by CYP3A4 in the liver.
Women use various forms of hormonal contraception. None of these have a known pharmacokinetic or pharmacodynamic interaction with tadalafil:
• Combined Hormonal Methods
Key Points
• No Known Drug–Drug Interaction
• Tadalafil does not affect estrogen or progestin levels.
• Hormones in birth control do not alter tadalafil metabolism significantly.
• Safety Profile
• Both are generally well tolerated together.
• Watch for common side effects of tadalafil (see below).
• Practical Advice
• No need to adjust birth control dose.
• Maintain your regular contraceptive schedule.
Antidepressants can influence sexual function and share metabolic pathways with many medications. Here’s how they line up with tadalafil:
Classes of Antidepressants
• Selective Serotonin Reuptake Inhibitors (SSRIs)
Drug Interaction Considerations
• Metabolism via CYP3A4
• Tadalafil is broken down by CYP3A4.
• Most SSRIs/SNRIs are metabolized by CYP2D6/1A2; only minimal CYP3A4 inhibition (e.g., fluvoxamine).
• Significant CYP3A4 inhibitors (ketoconazole, ritonavir) would raise tadalafil levels; antidepressants rarely pose this risk.
• Blood Pressure and Vasodilation
• Both antidepressants and tadalafil can lower blood pressure slightly.
• When combined, monitor for dizziness or lightheadedness, especially upon standing.
• Sexual Side Effects
• SSRIs and SNRIs commonly cause reduced libido, arousal difficulties or delayed orgasm.
• Tadalafil may help with arousal by increasing genital blood flow, but evidence in women is mixed.
• Bupropion has less impact on sexual function and may be preferred if sexual side effects are a concern.
Clinical Evidence
• Studies in Men vs. Women
• Most tadalafil research focuses on men with ED.
• Limited trials in women, showing variable benefit for female sexual dysfunction.
• Interaction Trials
• No major studies report adverse interactions between tadalafil and common antidepressants.
• Case reports suggest minimal risk, but individual responses vary.
Be aware of these when starting tadalafil. If you experience severe or persistent symptoms, speak to a healthcare professional.
• Headache
• Flushing (warmth or redness in face)
• Indigestion or heartburn
• Back pain or muscle aches
• Nasal congestion
• Dizziness (especially when getting up quickly)
• Vision changes (rare)
• Cardiovascular Conditions
• Unstable angina or severe heart failure.
• Recent stroke or myocardial infarction (< 6 months).
• Use of nitrates (e.g., nitroglycerin) or guanylate cyclase stimulators.
• Hypotension Risk
• Low baseline blood pressure (< 90/50 mm Hg).
• Concomitant alpha-blockers for prostate issues or blood pressure.
• Severe Liver or Kidney Disease
• Dose adjustments may be necessary.
Not sure which symptoms are important? Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Always seek prompt care or call emergency services if you experience:
• Chest pain, pressure or a sense of heaviness in chest or arm
• Sudden vision loss or changes in one or both eyes
• Sudden ringing in ears, dizziness or vertigo
• Prolonged erection lasting > 4 hours (priapism)
• Severe dizziness, fainting or rapid heartbeat
Current evidence suggests that tadalafil can be used safely by women on hormonal birth control with no significant interactions. When it comes to antidepressants, there’s also no major documented conflict, though you’ll want to watch for additive blood-pressure effects and the impact of antidepressant-related sexual side effects. Because individual medical histories vary—and because tadalafil is not FDA-approved for most female uses—it’s essential to:
• Speak to your doctor before starting tadalafil.
• Review all your medications and health conditions.
• Monitor for side effects, especially blood-pressure changes.
For anything life-threatening or seriously concerning, always reach out to a healthcare professional immediately. And if you’re unsure what’s normal or need guidance on your symptoms, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Remember: this information is not a substitute for personalized medical advice. Always consult your physician or qualified provider about your specific health needs.
(References)
* Rudkin L, Taylor MJ, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003382. doi: 10.1002/14651858.CD003382.pub2. Epub 2004 Oct 18. PMID: 15495050.
* Anghelescu I, Urbanek C. Tadalafil in a patient with treatment-resistant depression and antidepressant polypharmacy. J Clin Psychopharmacol. 2005 Apr;25(2):191-2. doi: 10.1097/01.jcp.0000155829.90079.fa. PMID: 15738756.
* Heidelbaugh JJ. Management of erectile dysfunction. Am Fam Physician. 2010 Feb 1;81(3):305-12. PMID: 20112889.
* Abdel-Raoof AM, Hasan MA, Madkour AW, Abdel-Fattah A, Eissa MS. Simultaneous determination of citalopram and tadalafil by the second derivative synchronous fluorescence method in biological fluids; application of Box-Behnken optimization design. Luminescence. 2021 Feb;36(1):57-65. doi: 10.1002/bio.3913. Epub 2020 Aug 3. PMID: 32678940.
* Ferreira PA, de Oliveira FM, de Melo EI, de Carvalho AE, Lucca BG, Ferreira VS, da Silva RAB. Multi sensor compatible 3D-printed electrochemical cell for voltammetric drug screening. Anal Chim Acta. 2021 Jul 18;1169:338568. doi: 10.1016/j.aca.2021.338568. Epub 2021 May 5. PMID: 34088376.
* Imani MH, Hassanpour S, Asghari A, Khaksar E. Parental exposure of Tadalafil has beneficial effect on reflexive motor behaviors in mice offspring. Int J Dev Neurosci. 2022 Aug;82(5):397-406. doi: 10.1002/jdn.10187. Epub 2022 Apr 29. PMID: 35471701.
* Duarte-Silva E, Oriá AC, Mendonça IP, Paiva IHR, Leuthier Dos Santos K, Sales AJ, de Souza JRB, Maes M, Meuth SG, Peixoto CA. The Antidepressant- and Anxiolytic-Like Effects of the Phosphodiesterase Type-5 Inhibitor Tadalafil are Associated with the Modulation of the Gut-Brain Axis During CNS Autoimmunity. J Neuroimmune Pharmacol. 2024 Aug 19;19(1):45. doi: 10.1007/s11481-024-10148-4. Epub 2024 Aug 19. PMID: 39158758.
* Derayea SM, Zaafan AAS, Nagy DM, Oraby M, Amir A, Zaafan S. Novel eco-friendly HPTLC method using dual-wavelength detection for simultaneous quantification of duloxetine and tadalafil with greenness evaluation and application in human plasma. Sci Rep. 2024 Oct 13;14(1):23907. doi: 10.1038/s41598-024-73523-4. Epub 2024 Oct 13. PMID: 39397048; PMCID: PMC11471823.
* Nagy DM, Derayea SM, Zaafan AAS, Oraby M. Development and validation of derivative UV spectroscopic methods for simultaneous estimation of duloxetine and tadalafil in their binary mixtures: greenness-blueness evaluation. BMC Chem. 2025 May 16;19(1):130. doi: 10.1186/s13065-025-01483-5. Epub 2025 May 16. PMID: 40380259; PMCID: PMC12083154.
* Tuominen JA, Riise T, Romanowska J, Flores-Torres MH, Cortese M, Scherzer CR, Bjornevik K, Igland J. Association of Medication Use and 8-Year Mortality Risk in Patients With Parkinson Disease: Drug-Wide Trial Emulation. Neurology. 2025 Aug 12;105(3):e213783. doi: 10.1212/WNL.0000000000213783. Epub 2025 Jul 11. PMID: 40644656; PMCID: PMC12264975.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.